Navigation Links
Find New Cancer Treatments at cureLauncher

Bloomfield Hills, MI (PRWEB) January 24, 2013

Less than 5 percent of Americans know where to find information about clinical trials, according to the Center for Information & Study on Clinical Research. cureLauncher solves that problem. It gives everyone a place to find new treatments and connect with lifesaving treatment options.

Now, cureLauncher has every enrolling breast cancer trial in the country available on its website. There are 400 trials at 7,500 locations across the U.S. that offer new breast cancer treatment options. cureLauncher has translated the complex, medical terminology into easy to understand English.

When people visit cureLauncher, they can review information about these trials and the entry questions to see if a trial is right for them. Anyone can complete the Request Form to participate or call cureLauncher directly to see if they qualify. This service is free to all users.

cureLauncher’s founders, Stephen Goldner and David Fuehrer, appeared on the Stupid Cancer Radio Program live from New York City on January 21st to discuss trial options. “cureLauncher makes it easy for people to find treatment that’s right for them”, said David Fuehrer. “Our mission is to provide a place where people feel comfortable learning about clinical trials and cutting edge, new medical treatments”.

Dr. Max Wicha, Director of the University of Michigan’s Cancer Center, was on the Stupid Cancer Show with cureLauncher. “Only about 3 percent of cancer patients decide to enter a clinical trial, even though the very best treatment for them may be in a trial”, said Dr. Wicha. “Particularly now, when we have so many new options to treat cancer it’s so important that patients understand they have options to get advantages of these leading treatments”.

To learn more, visit

About cureLauncher is an online community that connects people to lifesaving clinical trials across the U.S. Discover your power to find new cancer treatment options, right now.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cornell bioengineers discover the natural switch that controls spread of breast cancer cells
2. New Shared Synthetic Replikin Cancer Vaccines
3. NextBio Teams With Emory University and the Aflac Cancer Center to Improve Outcomes for Children with Medulloblastoma
4. Genetic basis of high-risk childhood cancer points to possible new drug treatment strategy
5. Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
6. University of Colorado Cancer Center Study Finds That Body's Ibuprofen, SPARC, Reduces Inflammation and Thus Bladder Cancer Development and Metastasis
7. The Blood Sugar-Cardiac-Cancer Connection
8. Join Cato BioVentures and Cancer Advances at Biotech Showcase 2013 & J.P. Morgan 31st Annual Healthcare Conference
9. Game changing diagnostic & prognostic prostate cancer genetic tests revealed by Jefferson
10. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
11. Breast cancer cells growing in 3D-matrix revert to normal
Post Your Comments:
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... ... November 24, 2015 , ... International Society for Pharmaceutical Engineering ... premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference took place ... the largest number of attendees in more than a decade. , “The ...
Breaking Biology Technology:
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):